Elevated expression of AKR1C2 and AKR1C3 in prostate cancer cells promotes angiogenesis in vitro

被引：0
|
作者：
Azzarello, Joseph
Wang, Shaobin
Fung, Kar-Ming
Kropp, Bradley P.
Lin, Hsueh-Kung
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)61342-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [1] AKR1C2 and AKR1C3 expression in adipose tissue: Association with body fat distribution and regulatory variants
    Ostinelli, Giada
    Vijay, Jinchu
    Vohl, Marie-Claude
    Grundberg, Elin
    Tchernof, Andre
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 527
  • [2] Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis
    Hevir, N.
    Vouk, K.
    Sinkovec, J.
    Ribic-Pucelj, M.
    Rizner, Lanisnik
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 191 (1-3) : 217 - 226
  • [3] Activin A Stimulates AKR1C3 Expression and Growth in Human Prostate Cancer
    Hofland, Johannes
    van Weerden, Wytske M.
    Steenbergen, Jacobie
    Dits, Natasja F. J.
    Jenster, Guido
    de Jong, Frank H.
    ENDOCRINOLOGY, 2012, 153 (12) : 5726 - 5734
  • [4] AKR1C3 as a target in castrate resistant prostate cancer
    Adeniji, Adegoke O.
    Chen, Mo
    Penning, Trevor M.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 136 - 149
  • [5] Analysis of tissue specific expression of aldo-keto redactases AKR1C3 and AKR1C3
    Hirakawa, Haruka
    Sawada, Hiroshi
    Takikawa, Shin-ichirou
    Hara, Akira
    Iino, Teruhiko
    ZOOLOGICAL SCIENCE, 2006, 23 (12) : 1208 - 1208
  • [6] Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
    Lewis, MJ
    Wiebe, JP
    Heathcote, JG
    BMC CANCER, 2004, 4 (1)
  • [7] Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
    Michael J Lewis
    John P Wiebe
    J Godfrey Heathcote
    BMC Cancer, 4
  • [8] Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer
    Nie, Mingyi
    Li, Tian
    Liu, Peng
    Wang, Xueni
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [9] Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
    Kljun, Jakob
    Pavlic, Renata
    Hafner, Eva
    Lipec, Tanja
    Moreno-Da Silva, Sara
    Tic, Primoz
    Turel, Iztok
    Budefeld, Tomaz
    Stojan, Jure
    Rizner, Tea Lanisnik
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the P13K/Akt proliferative signaling pathway in human prostate cancer cells
    Wang, Shaobin
    Yang, Qing
    Fung, Kar-Ming
    Lin, Hsueh-Kung
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 289 (1-2) : 60 - 66
12345